Where is damage someone needs to be blamed. In this case, management.
So, what can we blame them for? For a bad drug performance? Actually not, as compared to existing ones on the market it performed better and saver.
For the Placebo response? How, when in the end the placebo people's statements about their personal assessment is all we got? Was the Placebo response to be expected? To some degree yes, but not to that extent. IMO, we could hold them accountable for a too short trial duration and trial design. IMO, why did the participants on both arms still take their regular anti-depressants? Didn't that actually ask for a clouded result or is that a standard of care requirement?
Shareholders are in charge of the sp, big pharma will determine if there is value. And if yes, then that value will be independent of the actual sp as it set by the buyer / partner.
Just holding 100k shares but using this as an example to learn about what to expect when investing in stocks that develop treatments for all sorts of mental problems. Quite different to the cancer stocks, who would have thought.
GLTA
ACW Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)